Young blood stem cells restored key blood-forming and immune functions in aged mice without chemotherapy or radiation. Credit ...

A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors. But this strategy has been undermined by the tendency of T cells to ...

ANKTIVA drives NMIBC growth, pipeline upside, and a 40% pullback entry. Click here to read more about IBRX.

The FDA has granted Priority Review to Genentech’s sBLA for obinutuzumab (Gazyva) to treat primary membranous nephropathy, based on phase 3 MAJESTY data.

Pelareorep FDA Fast Track designation opens a registrational path for a viral immunotherapy targeting advanced anal cancer ...

Fixed-duration CLL treatment is changing management options for the condition. Here’s what it is, how it works, its potential ...

Chronic cannabidiol (CBD) treatment reduced excessive brain inflammation and partially restored impaired immune-cell function in a model of Gulf War Illness, according to a new study from researchers ...

B-cell depletion therapies in multiple sclerosis (MS) work in part by mobilizing protective B cells from the gut.

Why do some vaccines protect for a lifetime, while threats like tumors and viruses present such an ongoing challenge? The ...

A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors. But this strategy ...

Immunotherapy is a groundbreaking approach in cancer treatment that empowers the body’s own immune system to recognize and ...

Objectives The oral microbiome plays a critical role in modulating systemic inflammation, partly through its interactions ...